Skip to main content

Day: October 31, 2024

JAKKS Pacific Unveils Fall Launch of Nintendo, Legend of Zelda, and Metroid Prime Products Just in Time for the Holidays

JAKKS Pacific Fall LaunchJAKKS Pacific Unveils Fall Launch of Nintendo, Legend of Zelda, and Metroid Prime Products Just in Time for the HolidaysJAKKS Pacific Fall LaunchJAKKS Pacific Unveils Fall Launch of Nintendo, Legend of Zelda, and Metroid Prime Products Just in Time for the HolidaysJAKKS Pacific Fall LaunchJAKKS Pacific Unveils Fall Launch of Nintendo, Legend of Zelda, and Metroid Prime Products Just in Time for the HolidaysSANTA MONICA, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) — JAKKS Pacific, Inc. (NASDAQ: JAKK) is excited to announce the release of its highly anticipated Nintendo products this fall, just in time for the holiday shopping season. With a wide range of offerings from worldwide best-sellers to new figures and more, JAKKS Pacific is ensuring that fans of all ages will find something...

Continue reading

Marex Group plc Announces Pricing of U.S.$600 Million Senior Notes Offering

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) — Marex Group plc (Nasdaq: MRX) (“Marex”), the diversified global financial services platform, announced the pricing on October 30, 2024 of a public offering (the “Offering”) of U.S.$600 million aggregate principal amount of its 6.404% Senior Notes due 2029 (the “Notes”). The Notes will be issued at a price to the public equal to 100.000% of the principal amount thereof and will be senior unsecured obligations of Marex. The Offering is expected to close on or about November 4, 2024, subject to the satisfaction of customary closing conditions. Marex intends to use the net proceeds from the Offering for working capital, to fund incremental growth and for other general corporate purposes. Ian Lowitt, CEO of Marex, commented: “We are very pleased to announce this successful debt issuance which...

Continue reading

ibex Wave iX Translate Wins 2024 Generative AI Product of the Year Award

ibex Wave iX Translate Wins 2024 Generative AI Product of the Year Awardibex is redefining CX with Gen AIWASHINGTON, Oct. 31, 2024 (GLOBE NEWSWIRE) — ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced that ibex Wave iX Translate has earned the 2024 Generative AI Product of the Year Award, presented by TMC and Generative AI Expo, for helping clients improve the customer experience. “We are proud to win the Generative AI Product of the Year Award for our leadership in leveraging Gen AI to redefine customer experience,” said ibex CEO Bob Dechant. “Gen AI is changing the CX landscape, and ibex continues to lead the way by pioneering AI solutions that deliver innovative and transformative CX solutions. With ibex Wave...

Continue reading

e-therapeutics Announces Business Updates and Interim Results

LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) — e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced business updates, including its unaudited interim results for the six months to 31st July 2024. Ali Mortazavi, CEO, said: “We continue to make strong and rapid progress towards becoming a clinical-stage biotech company, as we advance our pipeline of novel GalOmic therapies, aiming to file our first IND submission in 2025. I am also excited about the ongoing evolution of HepNet. Our investment in AWS infrastructure demonstrates our commitment to integrating cutting-edge technologies across our platform. To further these efforts, we are thrilled to welcome Dr Lee Clewley as our Vice President of Applied AI and to announce the promotion of Dr Natalie...

Continue reading

Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales

Dr. Cavo’s expertise will advance the marketing and business development of KetoAir™, a handheld breathalyzer for ketogenic health FREEHOLD, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services, today announced that it has appointed Dr. Charles Cavo to its Scientific and Clinical Advisory Board. Dr. Charles Cavo is the co-founder and Chief Medical Officer of Pounds Transformation, founded to help patients successfully reach their health and wellness goals through a combination of medical and lifestyle interventions related to nutrition and exercise. Dr. Cavo specialized in family medicine as an OBGYN at the Hospital of Central Connecticut and was drawn to the challenge of the obesity epidemic in America...

Continue reading

First Advantage Completes Acquisition of Sterling Check for $2.2 Billion

Strengthens First Advantage’s global reach Extends First Advantage’s high-quality and cost-effective background screening, identity, and verification technology solutions for the benefit of both companies’ customers across industry verticals and geographies Enables increased investment in Artificial Intelligence and next-generation Digital Identification technologies for enhanced customer and applicant experienceATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ:FA), a leading global provider of employment background screening, identity, and verification solutions, today announced that it has completed its acquisition of Sterling Check Corp. (the “transaction”). Valued at $2.2 billion, including the assumption of Sterling’s outstanding debt, the acquisition combines industry leading platforms and innovative...

Continue reading

Ninepoint Partners Announces Final October 2024 Cash Distribution for Ninepoint Cash Management Fund – ETF Series

TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the final October 2024 cash distribution for the Ninepoint Cash Management Fund – ETF Series. The record date for the distribution is October 31, 2024. This distribution is payable on November 7, 2024. The per-unit final October distribution is detailed below:Ninepoint ETF Series Ticker Cash Distribution per unit Notional Distribution per unit CUSIPNinepoint Cash Management Fund NSAV $0.19008 $0.00000 65443X105About Ninepoint Partners Based in Toronto, Ninepoint Partners LP is one of Canada’s leading alternative investment management firms overseeing approximately $7 billion in assets under management and institutional contracts. Committed to helping investors explore innovative investment solutions that have the...

Continue reading

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

The implant demonstrates stability and consistent drug release, supporting further analytical testing and development SARASOTA, FL, Oct. 31, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced promising results from recent sterilization and dissolution tests of its SP-26 ketamine-loaded implant for fibromyalgia and chronic pain. These tests were conducted under the Company’s current development agreement with Sever Pharma Solutions. Previously, Silo disclosed that Sever Pharma Solutions initiated the scale-up, extrusion, and analytical testing of the SP-26 ketamine hydrochloride (ketamine HCL) polymer implants....

Continue reading

Banzai Launches Curate: A Groundbreaking AI-Driven Newsletter Solution

OpenAI-Powered Curate Automatically Writes and Publishes Newsletters, and Grows Subscribers SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced the launch of Curate, an AI-powered newsletter platform designed to streamline content creation and audience engagement for organizations of all sizes. Traditional newsletters require multiple professionals to write, edit, publish, and market. Leveraging OpenAI’s GPT-4o, Curate automates the newsletter creation process by writing relevant, branded articles that resonate with target audiences. Curate then publishes content to a branded website and lets users set up daily or weekly updates, keeping their audience engaged...

Continue reading

Samba TV Announces Acquisition of Semasio, Strengthening its Position in Contextual Targeting

Strategic Acquisition Deepens Samba TV’s Agency and Platform Partnerships and Expands Global Footprint With Semantic Analysis of the Open Web SAN FRANCISCO, Oct. 31, 2024 (GLOBE NEWSWIRE) — Samba TV, the leading provider of TV technology for audience data and omniscreen measurement, today announced its acquisition of Semasio, a global provider of contextual targeting and audience data solutions. This strategic acquisition enhances Samba TV’s capabilities in delivering privacy-first targeting across digital and connected TV (CTV) platforms, further solidifying its position as a leader in AI-powered omniscreen advertising. By acquiring Semasio, Samba TV will expand its global footprint as well as its capabilities for advertisers to define and reach granular audience segments through a unified approach that combines contextual, behavioral,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.